New pill could tame overactive thyroid in Graves' disease
NCT ID NCT06984627
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study tests a new drug called rilzabrutinib in 30 adults with Graves' disease, a condition where the thyroid makes too much hormone. The goal is to see if the drug can safely lower thyroid hormone levels and improve symptoms. Participants will take one of two doses for 16 weeks and be monitored closely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number : 1240001
RECRUITINGSherbrooke, Quebec, J1H 5N4, Canada
-
Investigational Site Number : 1240002
RECRUITINGSurrey, British Columbia, V3T 2V6, Canada
-
Investigational Site Number : 1240003
RECRUITINGCalgary, Alberta, T2N 4L7, Canada
-
Investigational Site Number : 2760001
RECRUITINGFrankfurt, 60590, Germany
-
Investigational Site Number : 2760002
RECRUITINGEssen, 45147, Germany
-
Investigational Site Number : 3800001
RECRUITINGMilan, Milano, 20122, Italy
-
Investigational Site Number : 3800002
RECRUITINGPisa, 56126, Italy
-
Investigational Site Number : 3800003
RECRUITINGPalermo, 90127, Italy
-
Investigational Site Number : 7240001
RECRUITINGPamplona, Navarre, 31008, Spain
-
Investigational Site Number : 7240002
RECRUITINGBarcelona, Catalunya [Cataluña], 08036, Spain
-
Investigational Site Number : 7240004
RECRUITINGSeville, Sevilla, 41009, Spain
-
Investigational Site Number : 8260001
RECRUITINGNewcastle upon Tyne, England, NE2 4HH, United Kingdom
-
Investigational Site Number : 8260003
RECRUITINGMilton Keynes, Buckinghamshire, MK6 5LD, United Kingdom
Conditions
Explore the condition pages connected to this study.